Current software used for assessment of the risk of Down's syndrome may give misleading risk estimates if applied to other abnormalities. Often the abnormality is reflected in maternal serum o-fetoprotein and human chorionic gonadotrophin levels and is then translated into a low risk for Down's syndrome that may not be recognized as significantly atypical of normality. We regard this as a serious deficiency in the current Down's syndrome risk reporting algorithm, and suggest a modification that allows the problem to be overcome.
Maternal serum screening is now widely used for detecting Down's syndrome during the second trimester of pregnancy. The most commonly used mathematical construct used to estimate Down's syndrome risks utilises the ratio of two Gaussian likelihoods to modify the maternal age related risk of Down's syndrome.l-' This paper discusses what we consider to be a potential problem in the risk estimate interpretation algorithm and indicates how this can be overcome by incorporating a simple enhancement.
As pointed out by Heyl et al., 3 abnormalities other than Down's syndrome often produce extremely low Down's syndrome risk estimates. This means that a low risk cannot legitimately be used to reassure a woman that her fetus is normal. Although it is appreciated by many medical staff that a very low risk estimate may be misleading, laboratory reports are often explained to patients by staff not specifically trained in risk screening. We therefore find it particularly concerning that abnormalities reflected in the maternal serum results that may indicate a low risk of Down's syndrome may, in fact, be significantly deviant from normality, and this fact may not be indicated on laboratory reports. It is therefore logical that some method for indication of deviation from Correspondence: Dr T M Reynolds, Chemical Pathology Department, Burton Hospital, Belvedere Road, Burton-upon-Trent DE13 ORB, UK. 578 normal should be included in the risk interpretation algorithm, preferably before the report generation stage, so that an 'atypicality' flag may be automatically appended to the risk estimate report.
The reason why abnormalities other than Down's syndrome result in low risks is simply that they produce a different pattern of changes in the analytes used to derive the risk estimates. Fetal Down's syndrome causes a decrease in the maternal serum alpha fetoprotein (AFP) concentration to approximately O·7 multiples of the median (MoM) and an elevation in human chorionic gonadotrophin (HCG) to approximately 2 MoM. I In Trisomy 13 pregnancies, HCG tends to be at nearly normal concentrations with variable AFP concentrations.v' In Trisomy 18 pregnancies, there is a tendency for HCG to be lower than in normal pregnancies whilst AFP may be either low or significantly elevated.v" In sex chromosome abnormalities, both the AFP and HCG concentrations vary from extremely low to quite elevated.f-! For historical reasons, the first stage in a clinician's interpretation of maternal screening results in pregnancy tends to be examination of the AFP multiple of the median for detection of neural tube defects. After this, the Down's syndrome risk may be examined and it is here that the problem arises because the Down's syndrome risk estimate calculation admits just two outcomes. Down's syndrome and normal. Any pattern of results that is closer to normal than to Down's syndrome will tend to be classified as normal, even if they are highly atypical of normal. (In a world of apples and oranges, lemons and grapefruits would be classified as oranges!) Our proposed solution is to incorporate a simple non-specific screen based on a well-known statistical measure of how far an observation differs from what we would expect for a normal outcome. If this is excessive and unlikely to be due to chance, then the result is flagged as atypical.
Other workers have overcome the problem of non-Down's syndrome anomalies by incorporating specific screens but since these other conditions are rarer than Down's syndrome, problems may arise in collecting enough data to generate population parameters. We propose the inclusion of a non-specific screen based on the Mahalanobis distance? to augment the existing Down's syndrome risk interpretation algorithm. Effectively, this involves determining whether or not the observations fall outside a suitably chosen contour of the probability density function of the normal outcomes. Any observations outside this contour are atypical of normal but current reporting practices would allow a low risk estimate to be returned. This is unsatisfactory because the low risk estimate may simply mean that the results are even more atypical of Down's syndrome that they are of normal. It is notable that Trisomy 18 pregnancies tend to produce such atypical low risk estimates.
The modification to the risk estimate interpretation algorithm that we suggest is illustrated in Fig. 1 . For a low risk, but atypical, pregnancy no risk estimate is reported and the possibility of an abnormal outcome is flagged. A low risk 'screen negative' result is therefore only given when the observations are within reasonable limits of what would be expected for a normal outcome and the Down's syndrome risk is low. It is noteworthy that the Mahalanobis distance is already present as the exponent in the formula used to calculate the Gaussian likelihoods before calculation of the likelihood ratio. This makes the inclusion of this non-specific screen a simple matter.
Computational details
Down's syndrome risk estimates are calculated using the Gaussian probability density functions. Expressing this in matrix algebra as previously describedr' Given an observation ! from a p
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Suppress rtsk flag result a9 atypIcal FIGURE 1. Proposed screening algorithm with nonspecific screen. Modifications to existing algorithm are shown in bold.
dimensional multivariate Gaussian distribution function with a mean vector I!:. and covariance matrix V, the question that we need to determine is whether or not the observation falls within or outside of a specified contour of 'normality'. If a is the probability that we consider is too unlikely for a result to be normal (e.g. 1070), then the Mahalanobis distance must be less than the (1-a)I00% contour for an observation to be accepted as 'typical'.
The multivariate Gaussian frequency distribution function can be written as: 2
The Mahalanobis distance (d) distribution with /I = P degrees of freedom, then the observation falls outside the (1a)I00% contour of 'typicality' and can be considered atypical. If less than three analytes are used, there are special case formulae for calculation of the Gaussian probability density function and special cases for the Mahalanobis distance can also be written: (2'9070) in the unaffected pregnancies (Table 4 ) is due to a population bias towards younger women 
METHODS AND RESULTS
To demonstrate how testing for atypicality might function in practice, we examined the performance of the modified reporting algorithm (Fig. I) for a set of abnormal and unaffected pregnancies using Down's syndrome risk estimates and Mahalanobis distances calculated for screening using AFP and HCG, using the population parameters described by Wald et al. (Table 1) 1. The results analysed were from 37 pregnancies with various abnormalities taken from the literaturev" and 2000 unaffected pregnancies taken from the database of the Gwent screening program. Unconjugated estriol results were not used because this analyte is not assayed by the Gwent screening program. Down's syndrome risks and Mahalanobis distances were calculated using in-house software. In the experience of the authors the population distributions for AFP and HCG approximate quite well to a Gaussian distribution beyond the truncation limits suggested by Wald et al.' and therefore these truncation limits were not used. Down's syndrome risk estimates and values for the Mahalanobis distance for the 37 abnormal pregnancies are given in Table 2 . Since a 'double test' was used, the Mahalanobis distances should be compared with quantiles of the>? distribution with II = 2 degrees of freedom. For 95070, 98% and 99070 these are given by 5'991,7'824 and 9'210 respectively. The data are plotted together with the 99070 contours of both normal and Down's syndrome distributions in Fig. 2 . Table 3 gives a summary of the performance of the screening algorithm for 5070, 2070 and 1070 contours. Table 4 summarizes the results for the normal pregnancies.
The Down's syndrome risks derived are only illustrative because in many cases the corresponding maternal ages were omitted from the original case reports. In order to determine the functionality of the Mahalanobis distance, a Down's syndrome risk was required and therefore a maternal age of 35 years was assumed for these where CJ denotes the standard deviation and p, the correlation between parameters I and 2 in the bivariate case. in the sample used for this example. The usual 'screen positive' rate in the South Wales screening program is 3' 5070. 9 We have shown that the current Down's syndrome screening risk reporting algorithm in current usage may produce misleadingly low risks and screen negative conclusions in cases where an abnormal pregnancy is manifest in the serum data. This is because the Down's syndrome risk estimate is exactly that: an estimate of the risk of Down's syndrome. Of course, in some cases, it may be possible for the clinician to spot the atypicality but this is unlikely to be performed systematically and consistently and also relies on the clinician having the time and expertise to overrule the reported risk and 'screen negative' conclusion.
It is of course possible to add specific screens for any defined abnormality but since Down's syndrome is the commonest single trisomy, it is difficult to collect enough data to define abnormal populations reliably. This may be achieved for trisomy 18 but if two specific screens are used, there still remains the problem of those cases that are atypical of normality, Down's syndrome and trisomy 18. This implies that a non-specific screen may be of significant benefit.
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In our sample of 37 abnormal pregnancies extracted from the literature'r" an additional 15 pregnancies were identified as atypical. The Down's syndrome risks produced for these pregnancies are generally very small. We are concerned that these low risks may lead to a false reassurance that a pregnancy is normal. However, the increase in amniocentesis rates if all atypical results were automatically referred for amniocentesis would be unmanageable. We are not, therefore, recommending this approach. Rather, if a set of results is atypical, this is an indication for a considered review of the case: for example, the gestation age used to calculate MoMs and hence risks, may be incorrect. It may be that atypicality simply suggests that extra vigilance is needed at an 18 week anomaly scan.
